Profusa (PFSA) Stock Price

Profusa Price

NASDAQ·CLOSED
1.69
​
Market closed

Earnings per share have grown at 205.1% per year over the last 2 years.

Profusa stock price

Access this data via the Eulerpool API

Profusa business model & stock analysis

NorthView Acquisition Corp. is a blank check company, which intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company is headquartered in New York City, New York and currently employs 0 full-time employees. The company went IPO on 2021-12-20. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The firm intends to focus its search on businesses that are focused on healthcare. The firm is not engaged in any business operations and has not generated any revenue.

Frequently asked questions about Profusa

Converted at the current exchange rate, the Profusa share trades at 1.50 EUR (1.69 USD).

The Profusa share (PFSA) is listed on 1 stock exchanges, including: NASDAQ (NVAC).

The revenue cannot currently be calculated for Profusa.

The profit cannot currently be calculated for Profusa.

The P/E ratio cannot be calculated for Profusa at the moment.

The P/S cannot be calculated for Profusa currently.

The Eulerpool Quality Score for Profusa is 2/10.

The ISIN of Profusa is US74319X2071. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Profusa is PFSA. The ticker symbol is used to trade Profusa shares on the stock exchange.

Fair ValueTerminal
1.49 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Dec 20, 2021
ISIN
US74319X2071
Cusip
66718N103
Market capitalization
2.30 M USDMicro Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.40
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-203.13 %
Gross Margin
—
EBIT Margin
—
Net Margin
—
EPS (Earnings Per Share)
-109.99 USD
Net Debt / EBIT
-6.58
Debt/Equity
-1.93
Last updated Oct 3, 2026, 2:15 AM

Profusa Peer Group

Profusa Ticker

NASDAQ · NVAC

All fundamentals and in-depth analysis of Profusa

Our stock analysis for Profusa stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Profusa. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.